Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for embryo implantation in women with endometriosis and recurrent implantation failure
IRCT20200421047152N6Phase 3Completed
- Sponsor
- ACECR
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometriosis and Recurrent Implantation Failure (RIF) comparing Prednisolone with Placebo (2 arms). Primary endpoints: Clinical pregnancy, Implantation rate and 1 more. Started Feb 2025; status: completed.
02
Drugs
prednisolone
03
Conditions
endometriosisRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20200421047152N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200421047152N6.